Distinct disease mutations in DNMT3A result in a spectrum of behavioral, epigenetic, and transcriptional deficits
Diana C. Beard,
Xiyun Zhang,
Dennis Y. Wu,
Jenna R. Martin,
Alyssa Erickson,
Jane Valeriane Boua,
Nicole Hamagami,
Raylynn G. Swift,
Katherine B. McCullough,
Xia Ge,
Austin Bell-Hensley,
Hongjun Zheng,
Cory W. Palmer,
Nicole A. Fuhler,
Austin B. Lawrence,
Cheryl A. Hill,
Thomas Papouin,
Kevin K. Noguchi,
Audrey McAlinden,
Joel R. Garbow,
Joseph D. Dougherty,
Susan E. Maloney,
Harrison W. Gabel
Affiliations
Diana C. Beard
Department of Neuroscience, Washington University School of Medicine, St. Louis, MO 63110, USA
Xiyun Zhang
Department of Neuroscience, Washington University School of Medicine, St. Louis, MO 63110, USA
Dennis Y. Wu
Department of Neuroscience, Washington University School of Medicine, St. Louis, MO 63110, USA
Jenna R. Martin
Department of Neuroscience, Washington University School of Medicine, St. Louis, MO 63110, USA
Alyssa Erickson
Department of Neuroscience, Washington University School of Medicine, St. Louis, MO 63110, USA
Jane Valeriane Boua
Department of Neuroscience, Washington University School of Medicine, St. Louis, MO 63110, USA
Nicole Hamagami
Department of Neuroscience, Washington University School of Medicine, St. Louis, MO 63110, USA
Raylynn G. Swift
Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Genetics, Washington University School of Medicine, St. Louis, MO 63110, USA
Katherine B. McCullough
Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Genetics, Washington University School of Medicine, St. Louis, MO 63110, USA
Xia Ge
Department of Radiology, Washington University School of Medicine, St. Louis, MO 63110, USA; Intellectual and Developmental Disabilities Research Center, Washington University School of Medicine, St. Louis, MO 63110, USA
Austin Bell-Hensley
Department of Biomedical Engineering, Washington University, St. Louis, MO 63110, USA; Department of Orthopedic Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA
Hongjun Zheng
Department of Orthopedic Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA
Cory W. Palmer
Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA; Intellectual and Developmental Disabilities Research Center, Washington University School of Medicine, St. Louis, MO 63110, USA
Nicole A. Fuhler
Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA; Intellectual and Developmental Disabilities Research Center, Washington University School of Medicine, St. Louis, MO 63110, USA
Austin B. Lawrence
Department of Pathology and Anatomical Science, University of Missouri School of Medicine, Columbia, MO 65212, USA
Cheryl A. Hill
Department of Pathology and Anatomical Science, University of Missouri School of Medicine, Columbia, MO 65212, USA
Thomas Papouin
Department of Neuroscience, Washington University School of Medicine, St. Louis, MO 63110, USA
Kevin K. Noguchi
Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA; Intellectual and Developmental Disabilities Research Center, Washington University School of Medicine, St. Louis, MO 63110, USA
Audrey McAlinden
Department of Orthopedic Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA
Joel R. Garbow
Department of Radiology, Washington University School of Medicine, St. Louis, MO 63110, USA; Intellectual and Developmental Disabilities Research Center, Washington University School of Medicine, St. Louis, MO 63110, USA
Joseph D. Dougherty
Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Genetics, Washington University School of Medicine, St. Louis, MO 63110, USA; Intellectual and Developmental Disabilities Research Center, Washington University School of Medicine, St. Louis, MO 63110, USA
Susan E. Maloney
Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA; Intellectual and Developmental Disabilities Research Center, Washington University School of Medicine, St. Louis, MO 63110, USA
Harrison W. Gabel
Department of Neuroscience, Washington University School of Medicine, St. Louis, MO 63110, USA; Intellectual and Developmental Disabilities Research Center, Washington University School of Medicine, St. Louis, MO 63110, USA; Corresponding author
Summary: Phenotypic heterogeneity in monogenic neurodevelopmental disorders can arise from differential severity of variants underlying disease, but how distinct alleles drive variable disease presentation is not well understood. Here, we investigate missense mutations in DNA methyltransferase 3A (DNMT3A), a DNA methyltransferase associated with overgrowth, intellectual disability, and autism, to uncover molecular correlates of phenotypic heterogeneity. We generate a Dnmt3aP900L/+ mouse mimicking a mutation with mild to moderate severity and compare phenotypic and epigenomic effects with a severe R878H mutation. P900L mutants exhibit core growth and behavioral phenotypes shared across models but show subtle epigenomic changes, while R878H mutants display extensive disruptions. We identify mutation-specific dysregulated genes that may contribute to variable disease severity. Shared transcriptomic disruption identified across mutations overlaps dysregulation observed in other developmental disorder models and likely drives common phenotypes. Together, our findings define central drivers of DNMT3A disorders and illustrate how variable epigenomic disruption contributes to phenotypic heterogeneity in neurodevelopmental disease.